Abstract:Sphingomyelin synthase 2 (SMS2) is an enzyme that catalyzes the conversion of phosphatidylcholine and ceramide to sphingomyelin and diacylglycerol, and it is crucial to cellular lipid metabolism. Using the technique of subtraction hybridization, we have isolated a full-length cDNA encoding SMS2 from rat testes, which shared 93 and 87% identity at the nucleotide level with SMS2 in mice and humans respectively. A specific polyclonal antibody was prepared against a 20 amino acid peptide of NH 2 -FSWPLSWPPGCFKSSCK… Show more
“…The human genome contains two of these genes, named SMS1 and SMS2. The corresponding enzymes fulfill essentially all criteria attributed previously to SM synthase and reside in organelles where SM synthesis is known to occur, namely the Golgi (SMS1) and plasma membrane (SMS2) (15,17). In line with these findings, Yamaoka et al (4) reported the expression cloning of human SMS1 using a mouse lymphoid cell line with severely reduced SM synthase activity and susceptibility to methyl--cyclodextrin-induced cell death.…”
mentioning
confidence: 63%
“…Together with the finding that SMS2 primarily resides at the plasma membrane, these observations indicate that SMS2 operates as the major if not only cell surface-associated SM synthase in HeLa cells. Because SMS2 is expressed in essentially all major tissues (15,17,36) and in a variety of mammalian cell lines (this study), we anticipate that the presence of a cell surface-associated SM synthase activity is a general feature of mammalian cells.…”
Sphingomyelin (SM) is a vital component of cellular membranes in organisms ranging from mammals to protozoa. Its production involves the transfer of phosphocholine from phosphatidylcholine to ceramide, yielding diacylglycerol in the process. The mammalian genome encodes two known SM synthase (SMS) isoforms, SMS1 and SMS2. However, the relative contributions of these enzymes to SM production in mammalian cells remained to be established. Here we show that SMS1 and SMS2 are co-expressed in a variety of cell types and function as the key Golgi-and plasma membrane-associated SM synthases in human cervical carcinoma HeLa cells, respectively. RNA interference-mediated depletion of either SMS1 or SMS2 caused a substantial decrease in SM production levels, an accumulation of ceramides, and a block in cell growth. Although SMS-depleted cells displayed a reduced SM content, external addition of SM did not restore growth. These results indicate that the biological role of SM synthases goes beyond formation of SM.
“…The human genome contains two of these genes, named SMS1 and SMS2. The corresponding enzymes fulfill essentially all criteria attributed previously to SM synthase and reside in organelles where SM synthesis is known to occur, namely the Golgi (SMS1) and plasma membrane (SMS2) (15,17). In line with these findings, Yamaoka et al (4) reported the expression cloning of human SMS1 using a mouse lymphoid cell line with severely reduced SM synthase activity and susceptibility to methyl--cyclodextrin-induced cell death.…”
mentioning
confidence: 63%
“…Together with the finding that SMS2 primarily resides at the plasma membrane, these observations indicate that SMS2 operates as the major if not only cell surface-associated SM synthase in HeLa cells. Because SMS2 is expressed in essentially all major tissues (15,17,36) and in a variety of mammalian cell lines (this study), we anticipate that the presence of a cell surface-associated SM synthase activity is a general feature of mammalian cells.…”
Sphingomyelin (SM) is a vital component of cellular membranes in organisms ranging from mammals to protozoa. Its production involves the transfer of phosphocholine from phosphatidylcholine to ceramide, yielding diacylglycerol in the process. The mammalian genome encodes two known SM synthase (SMS) isoforms, SMS1 and SMS2. However, the relative contributions of these enzymes to SM production in mammalian cells remained to be established. Here we show that SMS1 and SMS2 are co-expressed in a variety of cell types and function as the key Golgi-and plasma membrane-associated SM synthases in human cervical carcinoma HeLa cells, respectively. RNA interference-mediated depletion of either SMS1 or SMS2 caused a substantial decrease in SM production levels, an accumulation of ceramides, and a block in cell growth. Although SMS-depleted cells displayed a reduced SM content, external addition of SM did not restore growth. These results indicate that the biological role of SM synthases goes beyond formation of SM.
“…Consistent with our observation, studies of SMS2 function in sperm cell also suggest that SMS2 is important for reconstruction of plasma membrane structure. 30 SMS2 deficiency could alter signal transduction mediated by lipid raft-associated receptors. As reported, the interaction of SM and cholesterol drives the formation of plasma membrane rafts, 5 and the relative proportions of both SM and cholesterol appear critical for the stability and function of lipid rafts.…”
Background-NFB has long been regarded as a proatherogenic factor, mainly because of its regulation of many of the proinflammatory genes linked to atherosclerosis. Metabolism of sphingomyelin (SM) has been suggested to affect NFB activation, but the mechanism is largely unknown. SMS2 regulates SM levels in cell plasma membrane and lipid rafts and has a potential to regulate NFB activation. Methods and Results-To investigate the role of SMS2 in NFB activation we used macrophages from SMS2 knockout (KO) mice and SMS2 siRNA-treated HEK 293 cells. We found that NFB activation and its target gene expression are attenuated in macrophages from SMS2 KO mice in response to lipopolysaccharide (LPS) stimulation and in SMS2 siRNA-treated HEK 293 cells after tumor necrosis factor (TNF)-␣ simulation. In line with attenuated NFB activation, we found that SMS2 deficiency substantially diminished the abundance of toll like receptor 4 (TLR4)-MD2 complex levels on the surface of macrophages after LPS stimulation, and SMS2 siRNA treatment reduced TNF-␣-stimulated lipid raft recruitment of TNF receptor-1 (TNFR1) in HEK293 cells. SMS2 deficiency decreased the relative amounts of SM and diacylglycerol (DAG) and increased ceramide, suggesting multiple mechanisms for the decrease in NFB activation. Conclusions-SMS2 is a modulator of NFB activation, and thus it could play an important role in NFB-mediated proatherogenic process. Key Words: sphingomyelin synthase 2 Ⅲ sphingomyelin Ⅲ lipid rafts Ⅲ NFB Ⅲ atherosclerosis A therosclerosis is an inflammatory disease. The accumulation of macrophage-derived foam cells in the vessel wall is always accompanied by the production of a wide range of chemokines, cytokines, and growth factors. 1 These factors regulate the turnover and differentiation of immigrating and resident cells, eventually influencing plaque development. One of the key regulators of inflammation is NFB, 2 which has long been regarded as a proatherogenic factor, mainly because of its regulation of many of the proinflammatory genes linked to atherosclerosis. 3,4 Sphingomyelin (SM) is one of the major lipids on the plasma membrane and is enriched in lipid rafts, which are considered microdomains of plasma membrane critical for signal transduction. 5,6 Depletion of cholesterol from rafts causes a redistribution of TNF-␣ receptor 1 to nonraft plasma membrane, preventing NFB activation 7 or ligand-induced RhoA activation, 8 and such treatment also inhibits proinflammatory signals mediated by TLRs. 9 Studies also suggest that NFB activation is triggered by SM-derived ceramide. 10,11 On the contrary, it has been shown that ceramide is not necessary or even inhibits NFB activation. 12 SM biosynthesis might also affect NFB activation. SM is synthesized by sphingomyelin synthase (SMS), which transfers the phosphorylcholine moiety from phosphatidylcholine (PC) onto ceramide, producing SM and diacylglycerol (DAG). 13 Luberto et al 14 found that D609, a nonspecific SMS inhibitor, blocks TNF-␣-and phorbol ester-mediated NFB activation that was c...
“…In the seminiferous epithelium of rat testis, stage-specifi c expression of a form of SMS2 was localized to late round spermatids and early elongating spermatids and not present in late elongated spermatids or Sertoli cells ( 39 ). This enzyme was suggested to play a role in acrosome formation and the plasma membrane restructuring that occurs between late round spermatids and early elongating spermatids.…”
Mammalian spermatogenesis is an extraordinary cell transformation process. It includes asymmetric division of spermatogonia, rapid proliferation and differentiation into primary spermatocytes, a meiotic phase in which the genetic material in spermatocytes is recombined and segregated to produce haploid cells, a postmeiotic phase in which secondary spermatocytes develop into round spermatids, and differentiation of the latter into late spermatids and spermatozoa ( 1 ). During this last stage, known as spermiogenesis, spermatids undergo relevant cytological transformations, with changes in nuclear shape, chromatin condensation, formation of acrosome and fl agellum, and disposal of surplus organelles and materials by production and release of membrane-enclosed remnants known as "residual bodies" ( 2, 3 ). These minute, densely packed particles are then engulfed by Sertoli cells ( 4 ).The sphingomyelin (SM) ( 5 ) and ceramide (Cer) ( 6 ) of cells located in mammalian seminiferous tubules are rich in very long chain (C24 to C34) polyunsaturated fatty acids (VLCPUFA) of the n-6 or the n-3 series, the main ones being 28:4n-6 and 30:5n-6, followed by 32:5n-6 in the rat. These lipids belong to spermatogenic cells, as indicated by the facts that i) in the prepubertal rat testis, VLCPUFAcontaining species of SM and Cer are not detected; ii) in
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.